The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo-Reference-Cited by-同舟云学术

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

Published:2010-01-23 Issue:5 Volume:66 Page:869-880
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ackler Scott,Mitten Michael J.,Foster Kelly,Oleksijew Anatol,Refici Marion,Tahir Stephen K.,Xiao Yu,Tse Christin,Frost David J.,Fesik Stephen W.,Rosenberg Saul H.,Elmore Steven W.,Shoemaker Alexander R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-1232-1.pdf

Reference44 articles.

1. SEER Surveillance Epidemiology and End Results [homepage on the internet]. Bethesda: National Cancer Institute; c1973-2007 [updated 18 Dec 2007; cited 2 Jan 2008]. Cancer Stats Fact Sheet, Non-Hodgkin Lymphoma [top of page]. Available from: http://seer.cancer.gov/statfacts/html/nhl.html

2. Cvetkovic RS, Perry CM (2006) Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs 66:791–820

3. Orlowski RZ, Kuhn DJ (2008) Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14:1649–1657

4. Utecht KN, Kolesar J (2008) Bortezomib: a novel chemotherapeutic agent for hematologic malignancies. Am J Health Syst Pharm 65:1221–1231

5. Wei MC (2004) Bcl-2-related genes in lymphoid neoplasia. Int J Hematol 80:205–209

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

2. Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model;Cell Death & Disease;2024-01-09

3. A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma;Aging;2023-11-15

4. Recent advances and applications of peptide–agent conjugates for targeting tumor cells;Journal of Cancer Research and Clinical Oncology;2023-08-15

5. Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures;Cancers;2023-07-25